Works matching AU Cannon, Christopher P.

Results: 242
    1
    2
    3
    4

    Geographic and racial variability in kidney, cardiovascular and safety outcomes with canagliflozin: A secondary analysis of the CREDENCE randomized trial.

    Published in:
    Diabetes, Obesity & Metabolism, 2024, v. 26, n. 9, p. 3530, doi. 10.1111/dom.15685
    By:
    • Cardoza, Kathryn;
    • Kang, Amy;
    • Smyth, Brendan;
    • Yi, Tae Won;
    • Pollock, Carol;
    • Agarwal, Rajiv;
    • Bakris, George;
    • Charytan, David M.;
    • de Zeeuw, Dick;
    • Wheeler, David C.;
    • Zhang, Hong;
    • Cannon, Christopher P.;
    • Perkovic, Vlado;
    • Arnott, Clare;
    • Levin, Adeera;
    • Mahaffey, Kenneth W.
    Publication type:
    Article
    5
    6
    7

    Potential for residual cardiovascular risk reduction: Eligibility for icosapent ethyl in the VERTIS CV population with type 2 diabetes and atherosclerotic cardiovascular disease.

    Published in:
    Diabetes, Obesity & Metabolism, 2023, v. 25, n. 5, p. 1398, doi. 10.1111/dom.14965
    By:
    • Kim, Joseph M.;
    • Bhatt, Deepak L.;
    • Dagogo‐Jack, Samuel;
    • Cherney, David Z. I.;
    • Cosentino, Francesco;
    • McGuire, Darren K.;
    • Pratley, Richard E.;
    • Liu, Chih‐Chin;
    • Cater, Nilo B.;
    • Frederich, Robert;
    • Mancuso, James P.;
    • Cannon, Christopher P.
    Publication type:
    Article
    8

    Cardiorenal outcomes by indices of liver steatosis and fibrosis in individuals with type 2 diabetes and atherosclerotic cardiovascular disease: Analyses from VERTIS CV, a randomized trial of the sodium‐glucose cotransporter‐2 inhibitor ertugliflozin

    Published in:
    Diabetes, Obesity & Metabolism, 2023, v. 25, n. 3, p. 758, doi. 10.1111/dom.14923
    By:
    • Corbin, Karen D.;
    • Dagogo‐Jack, Samuel;
    • Cannon, Christopher P.;
    • Cherney, David Z.I.;
    • Cosentino, Francesco;
    • Frederich, Robert;
    • Liu, Jie;
    • Pong, Annpey;
    • Lin, Jianxin;
    • Cater, Nilo B.;
    • Pratley, Richard E.
    Publication type:
    Article
    9

    Canagliflozin and atrial fibrillation in type 2 diabetes mellitus: A secondary analysis from the CANVAS Program and CREDENCE trial and meta‐analysis.

    Published in:
    Diabetes, Obesity & Metabolism, 2022, v. 24, n. 10, p. 1927, doi. 10.1111/dom.14772
    By:
    • Li, Chao;
    • Yu, Jie;
    • Hockham, Carinna;
    • Perkovic, Vlado;
    • Neuen, Brendon L.;
    • Badve, Sunil V.;
    • Houston, Lauren;
    • Lee, Vivian Y. J.;
    • Barraclough, Jennifer Y.;
    • Fletcher, Robert A.;
    • Mahaffey, Kenneth W.;
    • Heerspink, Hiddo J. L.;
    • Cannon, Christopher P.;
    • Neal, Bruce;
    • Arnott, Clare
    Publication type:
    Article
    10

    Mediators of ertugliflozin effects on heart failure and kidney outcomes among patients with type 2 diabetes mellitus.

    Published in:
    Diabetes, Obesity & Metabolism, 2022, v. 24, n. 9, p. 1829, doi. 10.1111/dom.14769
    By:
    • Segar, Matthew W.;
    • Kolkailah, Ahmed A.;
    • Frederich, Robert;
    • Pong, Annpey;
    • Cannon, Christopher P.;
    • Cosentino, Francesco;
    • Dagogo‐Jack, Samuel;
    • McGuire, Darren K.;
    • Pratley, Richard E.;
    • Liu, Chih‐Chin;
    • Maldonado, Mario;
    • Liu, Jie;
    • Cater, Nilo B.;
    • Pandey, Ambarish;
    • Cherney, David Z. I.
    Publication type:
    Article
    11
    12
    13
    14

    The effects of canagliflozin on heart failure and cardiovascular death by baseline participant characteristics: Analysis of the CREDENCE trial.

    Published in:
    Diabetes, Obesity & Metabolism, 2021, v. 23, n. 7, p. 1652, doi. 10.1111/dom.14386
    By:
    • Arnott, Clare;
    • Li, Jing‐Wei;
    • Cannon, Christopher P.;
    • Zeeuw, Dick;
    • Neuen, Brendon L.;
    • Heerspink, Hiddo J. L.;
    • Charytan, David M.;
    • Agarwal, Anubha;
    • Huffman, Mark D.;
    • Figtree, Gemma A.;
    • Bakris, George;
    • Chang, Tara I‐Hsin;
    • Feng, Kent;
    • Rosenthal, Norman;
    • Zinman, Bernard;
    • Jardine, Meg J.;
    • Perkovic, Vlado;
    • Neal, Bruce;
    • Mahaffey, Kenneth W.
    Publication type:
    Article
    15
    16
    17

    High‐sensitivity C‐reactive protein, low‐density lipoprotein cholesterol and cardiovascular outcomes in patients with type 2 diabetes in the EXAMINE (Examination of Cardiovascular Outcomes with Alogliptin versus Standard of Care) trial.

    Published in:
    Diabetes, Obesity & Metabolism, 2018, v. 20, n. 3, p. 654, doi. 10.1111/dom.13136
    By:
    • Hwang, You‐cheol;
    • Morrow, David A.;
    • Cannon, Christopher P.;
    • Liu, Yuyin;
    • Bergenstal, Richard;
    • Heller, Simon;
    • Mehta, Cyrus;
    • Cushman, William;
    • Bakris, George L.;
    • Zannad, Faiez;
    • White, William B.
    Publication type:
    Article
    18
    19
    20

    Relationship of glycated haemoglobin and reported hypoglycaemia to cardiovascular outcomes in patients with type 2 diabetes and recent acute coronary syndrome events: The EXAMINE trial.

    Published in:
    Diabetes, Obesity & Metabolism, 2017, v. 19, n. 5, p. 664, doi. 10.1111/dom.12871
    By:
    • Heller, Simon R.;
    • Bergenstal, Richard M.;
    • White, William B.;
    • Kupfer, Stuart;
    • Bakris, George L.;
    • Cushman, William C.;
    • Mehta, Cyrus R.;
    • Nissen, Steven E.;
    • Wilson, Craig A.;
    • Zannad, Faiez;
    • Liu, Yuyin;
    • Gourlie, Noah M.;
    • Cannon, Christopher P.
    Publication type:
    Article
    21
    22
    23

    Cost and Cost-effectiveness of an Early Invasive vs Conservative Strategy for the Treatment of Unstable Angina and Non–ST-Segment Elevation Myocardial Infarction.

    Published in:
    JAMA: Journal of the American Medical Association, 2002, v. 288, n. 15, p. 1851, doi. 10.1001/jama.288.15.1851
    By:
    • Mahoney, Elizabeth M.;
    • Jurkovitz, Claudine T.;
    • Chu, Haitao;
    • Becker, Edmund R.;
    • Culler, Steven;
    • Kosinski, Andrzej S.;
    • Robertson, Debbie H.;
    • Alexander, Charles;
    • Nag, Soma;
    • Cook, John R.;
    • Demopoulos, Laura A.;
    • DiBattiste, Peter M.;
    • Cannon, Christopher P.;
    • Weintraub, William S.
    Publication type:
    Article
    24
    25

    Ability of Minor Elevations of Troponins I and T to Predict Benefit From an Early Invasive Strategy in Patients With Unstable Angina and Non-ST Elevation Myocardial Infarction.

    Published in:
    JAMA: Journal of the American Medical Association, 2001, v. 286, n. 19, p. 2405, doi. 10.1001/jama.286.19.2405
    By:
    • Morrow, David A.;
    • Cannon, Christopher P.;
    • Rifai, Nader;
    • Frey, Martin J.;
    • Vicari, Ralph;
    • Lakkis, Nasser;
    • Robertson, Debbie H.;
    • Hille, Darcy A.;
    • DeLucca, Paul T.;
    • DiBattiste, Peter M.;
    • Demopoulos, Laura A.;
    • Weintraub, William S.;
    • Braunwald, Eugene
    Publication type:
    Article
    26

    Effect of Sotagliflozin on Total Hospitalizations in Patients With Type 2 Diabetes and Worsening Heart Failure : A Randomized Trial.

    Published in:
    2021
    By:
    • Szarek, Michael;
    • Bhatt, Deepak L.;
    • Steg, Ph. Gabriel;
    • Cannon, Christopher P.;
    • Leiter, Lawrence A.;
    • McGuire, Darren K.;
    • Lewis, Julia B.;
    • Riddle, Matthew C.;
    • Voors, Adriaan A.;
    • Metra, Marco;
    • Lund, Lars H.;
    • Komajda, Michel;
    • Testani, Jeffrey M.;
    • Wilcox, Christopher S.;
    • Ponikowski, Piotr;
    • Lopes, Renato D.;
    • Banks, Phillip;
    • Tesfaye, Eshetu;
    • Ezekowitz, Justin A.;
    • Verma, Subodh
    Publication type:
    journal article
    27
    28
    29
    30
    31
    32
    33
    34
    35

    Ticagrelor vs. clopidogrel in patients with non-ST-elevation acute coronary syndrome with or without revascularization: results from the PLATO trial.

    Published in:
    European Heart Journal, 2014, v. 35, n. 31, p. 2083, doi. 10.1093/eurheartj/ehu160
    By:
    • Lindholm, Daniel;
    • Varenhorst, Christoph;
    • Cannon, Christopher P;
    • Harrington, Robert A;
    • Himmelmann, Anders;
    • Maya, Juan;
    • Husted, Steen;
    • Steg, Philippe Gabriel;
    • Cornel, Jan H;
    • Storey, Robert F;
    • Stevens, Susanna R;
    • Wallentin, Lars;
    • James, Stefan K
    Publication type:
    Article
    36
    37
    38
    39
    40
    41

    Patients with acute coronary syndromes and elevated levels of natriuretic peptides: the results of the AVANT GARDE-TIMI 43 Trial.

    Published in:
    European Heart Journal, 2010, v. 31, n. 16, p. 1993, doi. 10.1093/eurheartj/ehq190
    By:
    • Scirica, Benjamin M.;
    • Morrow, David A.;
    • Bode, Christoph;
    • Ruzyllo, Witold;
    • Ruda, Mikhail;
    • Oude Ophuis, Anthonius J.M.;
    • Lopez-Sendon, Jose;
    • Swedberg, Karl;
    • Ogorek, Michal;
    • Rifai, Nader;
    • Lukashevich, Valentina;
    • Maboudian, Mojdeh;
    • Cannon, Christopher P.;
    • McCabe, Carolyn H.;
    • Braunwald, Eugene
    Publication type:
    Article
    42
    43
    44
    45
    46
    47

    20. Major Cardiovascular Outcomes in the EXAMINE Trial According to ACE Inhibitor Use (12-OR).

    Published in:
    Nederlands Tijdschrift voor Diabetologie (NTvD), 2015, v. 13, n. 3, p. 75, doi. 10.1007/s12467-015-0041-x
    By:
    • Serné, E.H. (Erik);
    • White, William B.;
    • Wilson, Craig A.;
    • Bakris, George L.;
    • Bergenstal, Richard M.;
    • Cannon, Christopher P.;
    • Cushman, William C.;
    • Fleck, Penny R.;
    • Heller, Simon R.;
    • Kupfer, Stuart;
    • Mehta, Cyrus R.;
    • Menon, Venu;
    • Nissen, Steven E.;
    • Perez, Alfonso T.;
    • Zannad, Faiez
    Publication type:
    Article
    48
    49
    50